Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression

Audrey Eichenberger; Izabella Dutra de Abreu; Daniela Vela; Megan Tusken; Mary Molly Camp

doi:10.1007/978-3-030-94960-0_34

Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression

Audrey Eichenberger, Izabella Dutra de Abreu, Daniela Vela, Megan Tusken, Mary Molly Camp

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The investigators conducted a multicenter open-label longitudinal study with randomized placebo-controlled double-blind maintenance phase to evaluate the effect of risperidone augmentation of citalopram for relapse prevention in older patients with antidepressant-resistant depression.

Original language	English (US)
Title of host publication	Essential Reviews in Geriatric Psychiatry
Publisher	Springer International Publishing
Pages	189-191
Number of pages	3
ISBN (Electronic)	9783030949600
ISBN (Print)	9783030949594
DOIs	https://doi.org/10.1007/978-3-030-94960-0_34
State	Published - Jan 1 2022

Keywords

Antidepressant-resistant depression
Augmentation
Citalopram
Open-label longitudinal study
Randomized placebo-controlled study
Relapse prevention
Risperidone

ASJC Scopus subject areas

General Medicine
General Psychology

Access to Document

10.1007/978-3-030-94960-0_34

Cite this

@inbook{fd35c73d78bc4daeb75f3a9e6d190abd,

title = "Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression",

abstract = "The investigators conducted a multicenter open-label longitudinal study with randomized placebo-controlled double-blind maintenance phase to evaluate the effect of risperidone augmentation of citalopram for relapse prevention in older patients with antidepressant-resistant depression.",

keywords = "Antidepressant-resistant depression, Augmentation, Citalopram, Open-label longitudinal study, Randomized placebo-controlled study, Relapse prevention, Risperidone",

author = "Audrey Eichenberger and {de Abreu}, {Izabella Dutra} and Daniela Vela and Megan Tusken and Camp, {Mary Molly}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-3-030-94960-0_34",

language = "English (US)",

isbn = "9783030949594",

pages = "189--191",

booktitle = "Essential Reviews in Geriatric Psychiatry",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression

AU - Eichenberger, Audrey

AU - de Abreu, Izabella Dutra

AU - Vela, Daniela

AU - Tusken, Megan

AU - Camp, Mary Molly

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - The investigators conducted a multicenter open-label longitudinal study with randomized placebo-controlled double-blind maintenance phase to evaluate the effect of risperidone augmentation of citalopram for relapse prevention in older patients with antidepressant-resistant depression.

AB - The investigators conducted a multicenter open-label longitudinal study with randomized placebo-controlled double-blind maintenance phase to evaluate the effect of risperidone augmentation of citalopram for relapse prevention in older patients with antidepressant-resistant depression.

KW - Antidepressant-resistant depression

KW - Augmentation

KW - Citalopram

KW - Open-label longitudinal study

KW - Randomized placebo-controlled study

KW - Relapse prevention

KW - Risperidone

UR - http://www.scopus.com/inward/record.url?scp=85158972658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85158972658&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-94960-0_34

DO - 10.1007/978-3-030-94960-0_34

M3 - Chapter

AN - SCOPUS:85158972658

SN - 9783030949594

SP - 189

EP - 191

BT - Essential Reviews in Geriatric Psychiatry

PB - Springer International Publishing

ER -

Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this